MRI scans not catching all high grade prostate tumors

Jodelle Maglaya | | Health Imaging | Cardiac Imaging

According to investigators who reported their fidings at the Society of Urologic Oncology's 17th annual meeting, standard 12-core prostate biopsies need to be given regardless if there were no findings of prostate lesions on MRI scans.

Researchers found that in their study, 13 percent of high grade prostate tumors were not seen on a prostate MRI and later revealed by transrectal ultrasound (TRUS) 12-core biopsy. 

Lead investigator Eric Kim, MD and his colleagues at Washington University School of Medicine in St. Louis studied 84 men with negative prostate MRI who then underwent standard TRUS prostate biopsy. 

See results here:

Standard TRUS Prostate Biopsy Needed Despite Negative MRIs

Jodelle Maglaya

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Related Content

New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD
New AI program delivers rapid, accurate echo video assessments
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage
New scoring system accurately predicts coronary risk in women

Around the web

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.